Also, bladder cancer cells are sensitive to treatment with drugs that targeting the EGFR pathway, which has been shown to be a therapeutic target in dealing with advanced bladder cancer (Mason et al., 2009). This evidence concerns the gene EGFR and urinary bladder carcinoma.